ZJYL · Jin Medical International Ltd.
$1.90
+0.00 (+0.00%)
At close · Jul 17
Market Cap
$14.87M
Shares
7,827,383
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$20.69M
-12%
FY2025
Net Income
$1.19M
-67.6%
FY2025
Gross Margin
29.22%
-11.2pp
FY2025
Operating Margin
2.94%
-12.5pp
FY2025
Diluted EPS
$0.20
-50%
FY2025
Operating Cash Flow
$2.9M
+340.5%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| $20.69M | $23.5M | $19.82M | $19.19M | $20.76M | |
| — | — | $182.68K | $181.61K | -$9492 | |
| $14.64M | $14M | $13.04M | $12.99M | $14.4M | |
| $6.04M | $9.5M | $6.78M | $6.2M | $6.36M | |
| 29.22% | 40.43% | 34.23% | 32.3% | 30.64% | |
| $1.56M | $1.5M | $1.54M | $1.89M | $1.57M | |
| $2.53M | $3.26M | $1.92M | $1.77M | $1.67M | |
| $243.4K | $237.82K | $225.9K | $362.6K | $346.61K | |
| $5.44M | $5.86M | $3.92M | $4.07M | $3.73M | |
| $608.18K | $3.64M | $2.87M | $2.13M | $2.63M | |
| 2.94% | 15.48% | 14.47% | 11.1% | 12.67% | |
| $851.59K | $3.88M | $3.09M | $2.49M | $2.98M | |
| $789.07K | $466.52K | $182.68K | $181.61K | — | |
| $987.64K | $544.97K | $354.68K | $612.11K | — | |
| $1.6M | $4.18M | $3.22M | $2.74M | $2.88M | |
| $214.57K | $763.88K | $343.71K | $36.11K | $248.64K | |
| $1.19M | $3.68M | $2.88M | $2.71M | $2.63M | |
| 5.76% | 15.64% | 14.52% | 14.1% | 12.67% | |
| $189.95K | -$256.09K | — | — | — | |
| $823.54K | $4.52M | $2.38M | $1.21M | $3.23M | |
| USD/shares | $0.20 | $0.40 | $0.40 | $0.40 | $0.40 |
| USD/shares | $0.20 | $0.40 | $0.40 | $0.40 | $0.40 |
| shares | 7.83M | 7.82M | 7.26M | 6.75M | 6.75M |
| shares | 7.83M | 7.82M | 7.26M | 6.75M | 6.75M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Geography (USD)
| Component | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Overseas Market | $16,272,575 | $14,891,029 | $17,081,998 | $16,447,284 | — |
| China Domestic Market | $4,414,699 | $8,610,981 | $2,739,459 | $2,743,257 | — |
| China Domestic Market | — | — | — | — | $2,545,663 |
| Overseas Market | — | — | — | — | $18,218,610 |
By Product & Service (USD)
| Component | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Wheelchair | $16,222,561 | $14,866,699 | $16,348,133 | $15,622,273 | — |
| Other Products | $2,577,947 | $6,751,550 | $702,932 | — | — |
| Wheelchair Components | $1,886,766 | $1,883,761 | $2,770,392 | — | — |
| Wheelchair Components and Others | — | — | — | — | $2,558,815 |
| Wheelchair | — | — | — | — | $18,205,458 |
| Wheelchair Components and Others | — | — | — | $3,568,268 | — |